Followers | 250 |
Posts | 14020 |
Boards Moderated | 3 |
Alias Born | 07/07/2006 |
Friday, February 19, 2010 1:06:16 PM
Total sharecount roughly 130 million.
So market cap 143 minus 124 cash =
That leaves a stockmarket value of 20 million dollar for both their entire IP portfolio as well as their iplex stockpile which has a proven value in italy
Italy alone creates revenue of 10mln on 60-100 patients.
ie whatever timeframe, or trader you are, that is very very much undervalued by all standards.. let alone if ALS is a real card to play again for the company as recent data suggest.
Italian data allready hinted at positives in usage of Iplex, the SMALL (but monitored in accordance and with fda discussed guidelines) USA patient results same to indicate the same.
ALS market is 30.000 patients in the USA that are all going to die within 5-7 years, since about 5yrs is the life expectancy of someone with ALS. And Insmed sell IPLEX in italy for about 140.00 per patient per year. (Insmed spent about 500-600mln developping both iplex, running trials and figuring out how to produce this very difficult biologic (which iplex is)), so cost recovery is why price is so high, not the production cost.)
Retinopathy allready is a likely and high odds use for iplex :
http://www.rop.gu.se/prevention
Recent INSM News
- Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Confe • PR Newswire (US) • 05/20/2024 08:28:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:16:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:15:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:39:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:37:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:36:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:34:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:33:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:22:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:21:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:18:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:15:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:14:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 09:52:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 09:48:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 09:46:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 09:39:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 09:35:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 09:31:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 09:27:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 09:22:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2024 09:16:13 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/14/2024 08:06:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:18:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:05:02 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM